In Brief Dorothy Graves named assistant vice president and associate director for administration at Sylvester March 18, 2022Vol.48 No.11
Clinical Roundup ECOG-ACRIN opens NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations March 18, 2022Vol.48 No.11
Clinical Roundup University of Pittsburgh study finds malaria drug could combat chemotherapy-resistant head and neck cancers March 18, 2022Vol.48 No.11
Clinical Roundup OSUCCC – James study highlights impact of intersecting identities in cancer risk March 18, 2022Vol.48 No.11
Clinical Roundup Yale study identifies class of oncogenic fusions in lung and pancreatic cancer March 18, 2022Vol.48 No.11
Clinical Roundup Yale scientists discover pathogenic mechanism in hematological malignancies March 18, 2022Vol.48 No.11
Clinical Roundup Researchers measure drop in cancer detection in Ontario due to COVID-19 March 18, 2022Vol.48 No.11
Drugs & Targets FDA approves FoundationOne CDx as companion diagnostic for EGFR therapeutics targeting exon 19 deletions or exon 21 substitutions in NSCLC March 18, 2022Vol.48 No.11
Drugs & Targets Strata Oncology Sentinel Trial for personalized cancer recurrence monitoring enrolls first patient March 18, 2022Vol.48 No.11
